Judith Catella: New Evidence on Distal Deep Vein Thrombosis from the RIETE Registry
Judith Catella, Practitioner at the Department of Vascular Medicine at Lyon Civil Hospitals, shared on LinkedIn about a recent article she and her colleagues co-authored, published in JTH, adding:
”Delighted to share that our latest paper has just been published in the Journal of Thrombosis and Haemostasis (JTH)!
Our study, ‘Outcomes and Predictors of Complications After Distal Deep Vein Thrombosis: A Prospective Analysis of 8,488 Patients’, provides key clinical insights into the outcomes and risk factors associated with distal deep vein thrombosis complications.
You can read and download the full article for free (available for the next 50 days).
I would like to express my deepest gratitude to the RIETE Registry for providing the invaluable data that made this large-scale prospective analysis possible.
A very special and heartfelt thank you to Pr Manuel Monreal, the coordinator of the registry, who supported and guided me through this project with so much warmth, kindness, and dedication.
Huge thanks also to my co-author Jean-Philippe Galanaud for his invaluable collaboration, support, and expertise throughout this journey.
Happy reading!”
Title: Outcomes and predictors of complications after distal deep vein thrombosis: a prospective analysis of 8488 patients
Authors: Judith Catella, Jean Philippe Galanaud, Carmen Fernandez Martínez de Septién, Pablo Demelo-Rodríguez, Leticia Guirado, Reina Valle, José María Pedrajas, Beniamino Zalunardo, Benjamin Brenner, Manuel Monreal
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?
-
Sep 20, 2026, 00:50A Shared Platelet Factor 4–Targeted Immune Mechanism in Adenovirus Infection – NEJM
-
Sep 20, 2026, 00:46Julia R. Coleman: Platelet Biology and Sex Differences in the Plasma Milieu at AAST 2026